Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Puglisi

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Minerva Gastroenterologica E Dietologica|September 15, 2006
Role of Helicobacter pylori in patients with portal hypertensive gastropathy by liver cirrhosis hepatitis C virus-relatedG Urso, D Interlandi, M Puglisi, et al.
Science (New York, N.Y.)|June 2, 2022
Memristive technologies for data storage, computation, encryption, and radio-frequency communicationMario Lanza, Abu Sebastian, Wei D Lu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2012
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experienceL R Molife, S Alam, D Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeksM E R O'Brien, J S Myerson, J I G Coward, et al.
BMJ Open Respiratory Research|January 2, 2015
An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicityA R Minchom, K Saksornchai, J Bhosle, et al.
British Journal of Cancer|January 1, 1997
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and scheduleA Ballestrero, F Ferrando, A Garuti, et al.
Oncology|August 15, 2012
Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trialsB Basu, J Vitfell-Pedersen, V Moreno Garcia, et al.
British Journal of Cancer|October 27, 2012
Association of creatine kinase and skin toxicity in phase I trials of anticancer agentsV Moreno Garcia, P Thavasu, M Blanco Codesido, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 26, 1999
Spinal-flexibility-plus-aerobic versus aerobic-only training: effect of a randomized clinical trial on function in at-risk older adultsM C Morey, M Schenkman, S A Studenski, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Minerva Gastroenterologica E Dietologica|September 15, 2006
Role of Helicobacter pylori in patients with portal hypertensive gastropathy by liver cirrhosis hepatitis C virus-relatedG Urso, D Interlandi, M Puglisi, et al.
Science (New York, N.Y.)|June 2, 2022
Memristive technologies for data storage, computation, encryption, and radio-frequency communicationMario Lanza, Abu Sebastian, Wei D Lu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2012
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experienceL R Molife, S Alam, D Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeksM E R O'Brien, J S Myerson, J I G Coward, et al.
BMJ Open Respiratory Research|January 2, 2015
An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicityA R Minchom, K Saksornchai, J Bhosle, et al.
British Journal of Cancer|January 1, 1997
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and scheduleA Ballestrero, F Ferrando, A Garuti, et al.
Oncology|August 15, 2012
Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trialsB Basu, J Vitfell-Pedersen, V Moreno Garcia, et al.
British Journal of Cancer|October 27, 2012
Association of creatine kinase and skin toxicity in phase I trials of anticancer agentsV Moreno Garcia, P Thavasu, M Blanco Codesido, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 26, 1999
Spinal-flexibility-plus-aerobic versus aerobic-only training: effect of a randomized clinical trial on function in at-risk older adultsM C Morey, M Schenkman, S A Studenski, et al.
Pageof 5